2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catane, R; Clement, JJ; Gorman, MS; Johnson, RK; Wodinsky, I | 1 |
| Clement, JJ; Johnson, RK; Meaney, KF; Swiniarski, J; Wodinsky, I | 1 |
2 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Experimental Neoplasms
| Article | Year |
|---|---|
Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
Topics: Alkylating Agents; Animals; Aziridines; Benzoquinones; Cyclohexenes; Cyclophosphamide; Drug Therapy, Combination; Female; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Quinones; Semustine | 1980 |
Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cell Survival; Cyclohexenes; Leukemia P388; Leukemia, Experimental; Melanoma; Mice; Neoplasms, Experimental; Quinones; Radiation-Sensitizing Agents; Radioisotope Teletherapy | 1979 |